Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 3/20 | 0.52 |
| ▸ | ADORA2B | P29275 | 3/20 | 0.52 |
| ▸ | PRMT5 | O14744 | 4/20 | 0.51 |
| ▸ | WDR77 | Q9BQA1 | 4/20 | 0.51 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.48 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5685741 | 0.87 | ADORA2A (0.61) | ADORA2AADORA2BADORA3ADORA1 | |
| SCHEMBL7744261 | 0.87 | AHCY (0.46) | ADORA2AADORA2BPRMT5WDR77 | |
| SCHEMBL7161647 | 0.86 | ADORA2A (0.63) | ADORA2AADORA2BADORA3ADORA1 | |
| SCHEMBL29877256 | 0.86 | AHCY (0.61) | ADORA2AADORA2BADORA3ADORA1 | |
| SCHEMBL177772 | 0.86 | AHCY (0.61) | ADORA2AADORA2BADORA3ADORA1 | |
| SCHEMBL28901883 | 0.86 | AHCY (0.61) | ADORA2AADORA2BADORA3ADORA1 | |
| SCHEMBL1320875 | 0.85 | ADORA3 (0.64) | ADORA3 | |
| SCHEMBL258935 | 0.78 | ADORA3 (0.59) | ADORA2AADORA2BADORA3ADORA1 | |
| SCHEMBL4327814 | 0.76 | ADORA2A (0.53) | ADORA2AADORA2BPRMT5WDR77ADORA3 | |
| SCHEMBL7744279 | 0.75 | AHCY (0.47) | ADORA2AADORA2BPRMT5WDR77ADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0758897-B1 | COMPOUNDS HAVING ANTIHYPERTENSIVE, CARDIOPROTECTIVE, ANTI-ISCHEMIC AND ANTILIPOLYTIC PROPERTIES | AVENTIS PHARM PROD INC (US) | 2004-02-25 | — | — | EP | disclosed |
| US-6392049-B1 | NITRATION USING NITRIC ACID | AVENTIS PHARMACEUTICALS INC. | 2002-05-21 | — | — | US | disclosed |
| US-6307054-B1 | HEATING A 5-CARBOXY-2,4-DIHYROXYPYRIDINE AND PHOSPHORIC ACID WHERE THE RATIO OF PHOSPHORIC ACID TO WATER IS NOT LESS THAN ABOUT 27 TO 1 WEIGHT %. | AVENTIS PHARMACEUTICALS PRODUCTS INC. | 2001-10-23 | — | — | US | disclosed |
| EP-1006115-A2 | Imidazopyridines having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties | RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) | 2000-06-07 | — | — | EP | disclosed |
| US-5736554-A | TREATING AND/OR PREVENTING CARDIOVASCULAR DISORDERS | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1998-04-07 | — | — | US | disclosed |
| EP-0758897-A4 | COMPOUNDS HAVING ANTIHYPERTENSIVE, CARDIOPROTECTIVE, ANTI-ISCHEMIC AND ANTILIPOLYTIC PROPERTIES | RHONE POULENC RORER PHARMA (US) | 1997-11-19 | — | — | EP | disclosed |
| US-5652366-A | ADENOSINE AGONISTS; HYPOTENSIVE, CARDIOPROTECTIVE, ANTI-ISCHEMIC, AND ANTILIPOLYTIC AGENTS | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1997-07-29 | — | — | US | disclosed |
| EP-0758897-A1 | COMPOUNDS HAVING ANTIHYPERTENSIVE, CARDIOPROTECTIVE, ANTI-ISCHEMIC AND ANTILIPOLYTIC PROPERTIES | RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) | 1997-02-26 | — | — | EP | disclosed |
| US-5561134-A | ADENOSINE DERIVATIVES | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1996-10-01 | — | — | US | disclosed |
| WO-1995028160-A1 | COMPOUNDS HAVING ANTIHYPERTENSIVE, CARDIOPROTECTIVE, ANTI-ISCHEMIC AND ANTILIPOLYTIC PROPERTIES | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1995-10-26 | — | — | WO | disclosed |
| US-5364862-A | Adenosine derivatives | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1994-11-15 | — | — | US | disclosed |